40
Participants
Start Date
June 30, 2024
Primary Completion Date
May 31, 2025
Study Completion Date
September 30, 2025
Acetylsalicylic Acid
Patients will undergo CT imaging with the use of contrast for diagnosis of BCVI. Patients will be monitored for feasibility outcomes, as well as the development of stroke and bleeding complications.
Lead Sponsor
Western University
OTHER
London Health Sciences Centre
OTHER